GOLDMAN SACHS GROUP INC - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 77 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$681,053
-44.7%
582,097
+327.0%
0.00%
Q1 2024$1,232,306
+56.1%
136,317
+87.7%
0.00%
Q4 2023$789,368
-15.6%
72,619
-37.5%
0.00%
Q3 2023$935,418
+31.5%
116,201
+77.3%
0.00%
Q2 2023$711,580
-33.1%
65,523
-57.5%
0.00%
Q1 2023$1,063,697
+58.9%
154,159
-8.3%
0.00%
Q4 2022$669,321
+44196.6%
168,171
-26.0%
0.00%
Q3 2022$1,511
+586.8%
227,219
+398.5%
0.00%
Q2 2022$220
-100.0%
45,584
-71.0%
0.00%
Q1 2022$1,468,000
-18.4%
156,949
+3.5%
0.00%
Q4 2021$1,800,000
-33.8%
151,569
-36.6%
0.00%
-100.0%
Q3 2021$2,721,000
-35.4%
239,125
+1.8%
0.00%0.0%
Q2 2021$4,214,000
+18.3%
234,872
+2.1%
0.00%0.0%
Q1 2021$3,561,000
+363.7%
229,994
+265.2%
0.00%
Q4 2020$768,000
+88.2%
62,976
+98.5%
0.00%
Q3 2020$408,00031,7230.00%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 3,156,803$15,279,0003.01%
Lion Point Capital, LP 3,684,622$18,959,0002.16%
Bleichroeder LP 1,322,463$6,401,0001.32%
Bain Capital Life Sciences Investors, LLC 1,431,058$6,926,0000.81%
683 Capital Management, LLC 1,900,000$9,196,0000.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,510,831$16,992,0000.65%
Granite Point Capital Management, L.P. 472,056$2,285,0000.58%
Stonepine Capital Management, LLC 242,327$1,173,0000.55%
Avoro Capital Advisors LLC 3,150,000$15,246,0000.30%
Artal Group S.A. 1,000,000$4,840,0000.26%
View complete list of MARINUS PHARMACEUTICALS INC shareholders